D
Teva Pharmaceutical Industries Limited TEVA
$15.38 -$0.07-0.45% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025
Revenue 7.32% -7.99%
Total Other Revenue -- --
Total Revenue 7.32% -7.99%
Cost of Revenue 2.98% -4.50%
Gross Profit 11.99% -11.46%
SG&A Expenses 4.35% -3.47%
Depreciation & Amortization -- --
Other Operating Expenses 150.00% -92.86%
Total Operating Expenses 3.14% -4.62%
Operating Income 26.09% -20.60%
Income Before Tax -30.61% 219.03%
Income Tax Expenses -205.41% 164.29%
Earnings from Continuing Operations 28.18% 180.00%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- -110.34%
Net Income 31.78% 198.62%
EBIT 26.09% -20.60%
EBITDA 20.15% -17.99%
EPS Basic 30.80% 198.17%
Normalized Basic EPS 35.08% -38.75%
EPS Diluted 33.33% 193.99%
Normalized Diluted EPS 35.89% -39.86%
Average Basic Shares Outstanding 0.79% 0.44%
Average Diluted Shares Outstanding 0.17% 2.29%
Dividend Per Share -- --
Payout Ratio -- --